Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)
NCT05583019 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 88
Last updated 2023-08-15
Summary
The purpose of this research is to better understand how wrist-worn study devices that measure activity/motion ('accelerometry devices') can be used to assess scratching and sleep in participants aged 12-75 years, with and without Atopic Dermatitis (AD, eczema), in both a sleep laboratory (hotel) setting and in a daily life/home setting. In this study, we will be using three different wrist devices to collect information: an Apple Watch Series 7, an Actigraph CentrePoint Insights Watch (CPIW) and a GENEActiv Original Watch. We will also compare the movement and sleep measurements recorded on the devices to thermal video and sleep assessments done in the sleep laboratory (hotel) as well as compare them to Patient Reported Outcome (PRO) assessments.
Conditions
- Atopic Dermatitis
- Eczema
- Healthy
Interventions
- DEVICE
-
GENEActiv Accelerometry Device
a watch like wearable sensor
- DEVICE
-
Centrepoint Insights Watch (CPIW) Accelerometry Device
a watch like wearable sensor
- DEVICE
-
Apple Watch Accelerometry Device
a watch like wearable sensor
- DEVICE
-
Polysomnography
Sleep monitor
- DEVICE
-
Videography
Thermal Camera
Sponsors & Collaborators
-
SymmetryScience Group, Inc.
lead INDUSTRY
Principal Investigators
-
Mark B Moss, PhD · SymmetryScience Group, Inc.
Eligibility
- Min Age
- 12 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-10-27
- Primary Completion
- 2023-05-11
- Completion
- 2023-05-11
Countries
- United States
Study Locations
More Related Trials
-
A Study to Assess Disease Activity in Adolescent and Adult Participants With Atopic Dermatitis Who Receive Oral Upadacitinib Tablets in a Real-World Setting
NCT05139836 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Upadacitinib in Adolescent and Adult Patients With Moderate to Severe Atopic Dermatitis (Eczema)
NCT03569293 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess Treat-to-Target and Dosing Flexibility of Oral Upadacitinib Tablets in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT05507580 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Assess the Effect of Upadacitinib in Atopic Dermatitis-induced Sleep Disturbance in Adults With Moderate to Severe Atopic Dermatitis
NCT06390722 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03568318 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
A Study to Evaluate Upadacitinib in Adolescents and Adults With Moderate to Severe Atopic Dermatitis (Measure Up 2)
NCT03607422 ·Status: COMPLETED ·Phase: PHASE3
-
Skin Efficacy and Tolerability of a Cosmetic Product Combination Over 3 Months in Subjects With Atopic Eczema
NCT05790083 ·Status: UNKNOWN ·Phase: NA
-
Study of the Efficacy, Safety, and Tolerability of Serlopitant for Pruritus (Itch) in Atopic Dermatitis
NCT02975206 ·Status: COMPLETED ·Phase: PHASE2
-
Real World Study of Oral Upadacitinib Tablets to Assess Adverse Events and Change in Disease Activity in Adolescent and Adult Chinese Participants With Atopic Dermatitis
NCT05959083 ·Status: ACTIVE_NOT_RECRUITING
-
Skin Tracker: A Mobile Health App to Monitor Skin Disease Activity and Treatment Use
NCT04404075 ·Status: COMPLETED
-
Anti-relapse Efficacy and Tolerance Assessment of a Cosmetic Cream for Very Dry, Irritated to Atopic Sensitive Skin.
NCT05575882 ·Status: RECRUITING ·Phase: NA
-
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
NCT06389136 ·Status: RECRUITING ·Phase: PHASE3
-
An Observational Study to Assess Change in Disease Activity and Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in Real World
NCT05669794 ·Status: ACTIVE_NOT_RECRUITING
-
Cetaphil Restoraderm Effect on Young Children With Atopic Dermatitis
NCT02589392 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess Treatment Patterns, Clinical Outcomes, and Healthcare Resource Utilization in Chinese Participants Receiving Upadacitinib for Atopic Dermatitis (AD) Through Chart Review
NCT06503536 ·Status: COMPLETED
-
Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis
NCT06412094 ·Status: COMPLETED ·Phase: NA
-
Collection of Clinical and Instrumental Data in Adult Subjects Suffering From Atopic Dermatitis
NCT04553224 ·Status: COMPLETED ·Phase: NA
-
Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up
NCT00795496 ·Status: COMPLETED
-
Neuropsychologic Assessments of Dupilumab-Treated Adolescent Participants With Moderate-to-Severe Atopic Dermatitis
NCT05203380 ·Status: COMPLETED
-
Wearable Skin Sensors to Assess Nocturnal Scratch Behavior
NCT03770858 ·Status: COMPLETED
-
Topical Steroid Formulation and Wet Wraps
NCT02680301 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Growth and Bone Mineral Density in Children With Atopic Dermatitis (AD) Treated With Dupilumab
NCT07187089 ·Status: WITHDRAWN ·Phase: PHASE4
-
A Study to Investigate Safety and Efficacy of Tapinarof Cream, 1% in Participants Ages 3 Months to < 24 Months With Atopic Dermatitis
NCT07265479 ·Status: RECRUITING ·Phase: PHASE3
-
TLA in Children With Moderate to Severe Atopic Eczema (TLA4AE)
NCT03795506 ·Status: RECRUITING ·Phase: NA
-
A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis
NCT03738397 ·Status: COMPLETED ·Phase: PHASE3